What is PharmaScript?
PharmaScript Specialty Pharmacy operates as a dedicated provider of home infusion therapy, focusing on delivering essential medications with exceptional compounding accuracy and leveraging advanced technology. Established in 2016, the company collaborates with healthcare professionals and insurance providers to optimize medication costs for patients while simultaneously improving health outcomes. Their specialized services cater to individuals requiring complex pharmaceutical care within a home setting, with nationwide delivery of compound medications highlighting their commitment to superior patient support.
How much funding has PharmaScript raised?
PharmaScript has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for PharmaScript?
The recent major strategic investment signifies a pivotal moment for PharmaScript, likely enabling the company to scale its operations, enhance its technological infrastructure, or pursue strategic acquisitions within the home infusion and specialty pharmacy market. Given the large-scale late-stage funding context, PharmaScript is expected to focus on market consolidation, expanding its service reach, and further solidifying its competitive advantage through innovation and operational efficiency. This capital infusion is critical for navigating the evolving healthcare landscape and meeting the growing demand for specialized home-based pharmaceutical care.
See full PharmaScript company page
